You are here

  • Home
  • Archive
  • Volume 33, Issue 8
  • CINOVA: a phase II study of CPC634 (nanoparticulate docetaxel) in patients with platinum resistant recurrent ovarian cancer

Article metrics

Article menu
Download PDFPDF
Original research
CINOVA: a phase II study of CPC634 (nanoparticulate docetaxel) in patients with platinum resistant recurrent ovarian cancer

 

Online download statistics by month:

Online download statistics by month: April 2023 to September 2024

AbstractFullPdf
Apr 202364786
May 202349898
Jun 202310511
Jul 202328667
Aug 20234952512
Sep 2023182118
Oct 202315940
Nov 202316475
Dec 202317398
Jan 202415157
Feb 20241511314
Mar 202415565
Apr 202415710
May 202415764
Jun 202415474
Jul 202417132
Aug 202411312
Sep 20247371
Total399112994